SCHEMBL6590019

SCHEMBL6590019

O=C(Nc1ccnc(NC2CCNCC2)n1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 1/20 0.53
▸ TTK P33981 1/20 0.53
▸ AURKB Q96GD4 1/20 0.53
▸ INCENP Q9NQS7 1/20 0.53
▸ HDAC1 Q13547 1/20 0.51
▸ HRH3 Q9Y5N1 3/20 0.50
▸ HRH4 Q9H3N8 2/20 0.50
▸ MAPK8 P45983 2/20 0.49
▸ IKBKB O14920 1/20 0.49
▸ CCNT1 O60563 1/20 0.48
▸ CDK9 P50750 1/20 0.48
▸ IRAK4 Q9NWZ3 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ MKNK1 Q9BUB5 1/20 0.47
▸ CYP1A2 P05177 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ CCR8 P51685 1/20 0.43
▸ CDK2 P24941 2/20 0.43
▸ CSNK2A1 P68400 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL821691 0.79 MEN1 (0.64) MEN1KMT2ACYP1A2CYP2C19
Hydrochloric Acid SCHEMBL6923547 0.75 MEN1 (0.49) AURKATTKAURKBINCENPMAPK8
SCHEMBL19477097 0.75 HRH3 (0.56) HRH3HRH4MAPK8IKBKBIRAK4
SCHEMBL3512300 0.73 TYK2 (0.52) MAPK8CDK9EGFR
SCHEMBL12389843 0.72 IKBKB (0.58) AURKBHRH3HRH4MAPK8IKBKB
Hydrochloric Acid SCHEMBL3777082 0.71 IKBKB (0.57) AURKBHRH3HRH4MAPK8IKBKB
SCHEMBL6878850 0.71 MCHR1 (0.58) AURKB
SCHEMBL6878847 0.71 MCHR1 (0.58) AURKB
SCHEMBL19073177 0.70 KMT2A (0.64) MEN1KMT2A
SCHEMBL18549055 0.70 KMT2A (0.64) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0912552-B1 2,4-DIAMINOPYRIMIDINE DERIVATES AS DOPAMINE D4 RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2004-04-21 — — EP disclosed
US-6395742-B1 PSYCHOLOGICAL DISORDERS JANSSEN PHARMACEUTICA N.V. (BE) 2002-05-28 — — US disclosed
US-6159982-A 2,4-diaminopyrimidine derivates as dopamine D4 receptor antagonist JANSSEN PHARMACEUTICA N. V. (BE) 2000-12-12 — — US disclosed
EP-0912552-A1 2,4-DIAMINOPYRIMIDINE DERIVATES AS DOPAMINE D4 RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 1999-05-06 — — EP disclosed
WO-1997043279-A1 2,4-DIAMINOPYRIMIDINE DERIVATES AS DOPAMINE D4 RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 1997-11-20 — — WO disclosed
Send feedback